Epilepsy Research
Volume 30, Issue 3 , Pages 187-194 , May 1998

Histaminergic mechanisms in amygdaloid-kindled seizures in rats

Received 27 August 1997 ,Revised 10 October 1997 ,Accepted 18 December 1997.

References 

  1. Callaghan DA, Schwark WS. Involvement of catecholamines in kindled amygdaloid convulsions in the rat. Neuropharmacology. 1979;18:541–545
  2. Corcoran M, Mason ST. Role of forebrain catecholamines in amygdaloid kindling. Brain Res. 1980;190:473–484
  3. De Groot J. The rat forebrain in stereotaxic coordinates. Verh. K. Ned. Acad. Wet. Natuurkund. 1959;52:1–40
  4. Engel J, Sharpless NS. Long-lasting depletion of dopamine in the rat amygdala induced by kindling stimulation. Brain Res. 1977;136:381–386
  5. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain—I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dope in various regions of the brain. J. Neurochem. 1966;13:655–669
  6. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 1969;25:295–330
  7. Kamei C, Oka M, Masuda Y, Yoshida K, Shimizu M. Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) and some antiepileptics on the kindled seizures in the neocortex, hippocampus and amygdala in rats. Arch. Int. Pharmacodyn. 1981;249:164–176
  8. Kamei C, Okumura Y, Tasaka K. Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology. 1993;111:376–382
  9. Munkenbeck KE, Schwark WS. Serotonergic mechanisms in amygdaloid-kindled seizures in the rat. Exp. Neurol. 1982;76:246–253
  10. Onodera K, Tuomisto L, Tacke U, Airaksinen M. Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats. Methods Find. Exp. Clin. Pharmacol. 1992;14:13–16
  11. Racine RJ. Modification of seizure activity by electrical stimulation: I. After-discharge threshold. Electroencephalogr. Clin. Neurophysiol. 1972;32:269–279
  12. Sato M, Nakashima T. Kindling: secondary epileptogenesis, sleep and catecholamines. Can. J. Neurol. Sci. 1975;2:439–446
  13. Shimoda Y, Koizumi A, Tanaka K. Electroencephalographic activation of ‘Diencephalic epilepsy’ with diphenhydramine. Yonago Acta Med. 1960;4:99–102
  14. Tuomisto L, Tacke U. Is histamine an anticonvulsive inhibitory transmitter?. Neuropharmacology. 1986;25:955–958
  15. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984;295:13–25
  16. Yokoyama H, Onodera K, Maeyama K, Yanai K, Iinuma K, Tuomisto L, et al. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of α-fluoromethylhistidine and metoprine, Naunyn-Schmiedeberg’s. Arch. Pharmacol. 1992;346:40–45
  17. Yokoyama H, Sato M, Iinuma K, Onodera K, Watanabe T. Centrally acting histamine H1-antagonists promote the development of amygdala kindling in rats. Neurosci. Lett. 1996;217:194–196

PII: S0920-1211(98)00005-9

Epilepsy Research
Volume 30, Issue 3 , Pages 187-194 , May 1998

Article Tools

* Image Usage & Resolution